KMT2A and acute myeloid leukemia: We report the prevalence of AML1-ETO, PML-RARA, CBFB-MYH11, BCR-ABL1p210 and MLL-AF9 in a Mexican pediatric population with newly diagnosed AML recruited between January 2019 and June 2021.